These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 27766418)

  • 1. The effects of high serum growth hormone and IGF-1 levels on bone mineral density in acromegaly.
    Tuzcu S; Durmaz ŞA; Carlıoğlu A; Demircan Z; Tuzcu A; Beyaz C; Tay A
    Z Rheumatol; 2017 Oct; 76(8):716-722. PubMed ID: 27766418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of GH-IGF-I excess and gonadal status on bone mineral density and body composition in patients with acromegaly.
    Madeira M; Neto LV; de Lima GA; Moreira RO; de Mendonça LM; Gadelha MR; Farias ML
    Osteoporos Int; 2010 Dec; 21(12):2019-25. PubMed ID: 20306022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum GH and IGF-I are significant determinants of bone turnover but not bone mineral density in active acromegaly: a prospective study of more than 70 consecutive patients.
    Ueland T; Fougner SL; Godang K; Schreiner T; Bollerslev J
    Eur J Endocrinol; 2006 Nov; 155(5):709-15. PubMed ID: 17062887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lowered ghrelin levels in acromegaly—normalization after treatment].
    Kozakowski J; Rabijewski M; Zgliczyński W
    Endokrynol Pol; 2005; 56(6):862-70. PubMed ID: 16821203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In acromegaly, increased bone mineral density (BMD) is determined by GH-excess, gonadal function and gender.
    Zgliczynski W; Kochman M; Misiorowski W; Zdunowski P
    Neuro Endocrinol Lett; 2007 Oct; 28(5):621-8. PubMed ID: 17984937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential presentation of cortical and trabecular peripheral bone mineral density in acromegaly.
    Jockenhövel F; Rohrbach S; Deggerich S; Reinwein D; Reiners C
    Eur J Med Res; 1996 May; 1(8):377-82. PubMed ID: 9360937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term maintenance of the anabolic effects of GH on the skeleton in successfully treated patients with acromegaly.
    Biermasz NR; Hamdy NA; Pereira AM; Romijn JA; Roelfsema F
    Eur J Endocrinol; 2005 Jan; 152(1):53-60. PubMed ID: 15762187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone, insulin growth factor-1, and igf binding protein-3 axis relationship with bone mineral density among healthy men.
    Krassas GE; Papadopoulou P; Koliakos G; Konstantinidis T; Kalothetou K
    Arch Androl; 2003; 49(3):191-9. PubMed ID: 12746097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy.
    Thorén M; Hilding A; Brismar T; Magnusson P; Degerblad M; Larsson L; Sääf M; Baylink DJ; Mohan S
    J Bone Miner Res; 1998 May; 13(5):891-9. PubMed ID: 9610754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body mass index and insulin-like growth factor 1 as risk factors for discordant growth hormone and insulin-like growth factor 1 levels following pituitary surgery in acromegaly.
    Zhang S; Li Y; Guo X; Gao L; Lian W; Yao Y; Feng M; Bao X; Wang R; Xing B
    J Formos Med Assoc; 2018 Jan; 117(1):34-41. PubMed ID: 28341329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age, body mass index, current smoking history, and serum insulin-like growth factor-I levels associated with bone mineral density in middle-aged Korean men.
    Rhee EJ; Oh KW; Lee WY; Kim SW; Oh ES; Baek KH; Kang MI; Park CY; Choi MG; Yoo HJ; Park SW
    J Bone Miner Metab; 2004; 22(4):392-8. PubMed ID: 15221500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopenia occurs in a minority of patients with acromegaly and is predominant in the spine.
    Kayath MJ; Vieira JG
    Osteoporos Int; 1997; 7(3):226-30. PubMed ID: 9205635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.
    Peacey SR; Toogood AA; Veldhuis JD; Thorner MO; Shalet SM
    J Clin Endocrinol Metab; 2001 Jan; 86(1):259-66. PubMed ID: 11232010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of growth hormone receptor activation by pegvisomant may increase bone density in acromegaly.
    Jimenez C; Ayala-Ramirez M; Liu J; Nunez R; Gagel RF
    Horm Metab Res; 2011 Jan; 43(1):55-61. PubMed ID: 21104581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
    Marzullo P; Di Somma C; Pratt KL; Khosravi J; Diamandis A; Lombardi G; Colao A; Rosenfeld RG
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mineral density of the axial skeleton in acromegaly.
    Ho PJ; Fig LM; Barkan AL; Shapiro B
    J Nucl Med; 1992 Sep; 33(9):1608-12. PubMed ID: 1517833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism.
    Colao A; Di Somma C; Pivonello R; Loche S; Aimaretti G; Cerbone G; Faggiano A; Corneli G; Ghigo E; Lombardi G
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1919-24. PubMed ID: 10372687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone-dependent insulin-like growth factor binding protein is a major determinant of bone mineral density in healthy men.
    Johansson AG; Forslund A; Hambraeus L; Blum WF; Ljunghall S
    J Bone Miner Res; 1994 Jun; 9(6):915-21. PubMed ID: 7521562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum leptin levels in patients with acromegaly before and after correction of hypersomatotropism by trans-sphenoidal surgery.
    Damjanović SS; Petakov MS; Raicević S; Micić D; Marinković J; Dieguez C; Casanueva FF; Popović V
    J Clin Endocrinol Metab; 2000 Jan; 85(1):147-54. PubMed ID: 10634378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of growth hormone (GH) and insulin-like growth factor I on prostate diseases: an ultrasonographic and endocrine study in acromegaly, GH deficiency, and healthy subjects.
    Colao A; Marzullo P; Spiezia S; Ferone D; Giaccio A; Cerbone G; Pivonello R; Di Somma C; Lombardi G
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1986-91. PubMed ID: 10372698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.